Trandolapril - NDSRI's
References
FAQ's
References
- Urbach, Hansjoerg; Henning, Rainer; Teetz, Volker; Geiger, Rolf; Becker, Reinhard, Derivatives Of Bicyclic Amino Acids, Process For Their Preparation, Agents Containing Them And Their Use, As Well As Bicyclic Amino Acids As Intermediates, And Process For Preparing Them, Hoechst A.-G., Federal Republic of Germany, EP84164B1, January 28, 1987
- Leena A. Al-Hawash, Ashok K. Shakya, and Maher L. Saleem, Stability-Indicating HPLC Determination of Trandolapril in Bulk Drug and Pharmaceutical Dosage Forms, Int J Anal Chem. 2015; 2015: 820517, 2015 Jan 31
Frequently Asked Questions
Do its impurities impact the pharmacokinetics of Trandolapril?
The impurities present in Trandolapril can influence its pharmacokinetics, resulting in alterations in bioavailability, metabolism, and elimination processes.
Which solvents help in the analysis of Trandolapril impurities?
Methanol and DCM are used as a solvent in analytical techniques to separate and detect Trandolapril impurities.
What steps can manufacturers take to control impurity levels in Trandolapril?
Manufacturers can employ strategies to maintain control over impurity levels in Trandolapril. They include utilizing premium-grade starting materials, carefully optimizing reaction conditions, implementing efficient purification techniques, and continuously monitoring impurity levels at every stage of the manufacturing process.
What are the temperature conditions required to store Trandolapril Impurities?
Trandolapril Impurities should be stored at a controlled room temperature between 2-8°C or as indicated on the Certificate of Analysis (CoA).
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.